EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Effect of radiation fractionation on IDO1 via the NF-κB/COX2 axis in non-small cell lung cancer

Yanli Lan, Wenhu Pi, Zhangjie Zhou, Yinnan Meng, DanMei, Yixiu Xu, Xinhang Xia, WeiWang, HaiHua Yang, Feng-Ming Spring Kong

International Immunopharmacology · 2023

DOI: 10.1016/j.intimp.2023.110956 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2023. Verfasst von Yanli Lan und 9 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Radiation Oncology of Taizhou, Radiation Oncology Institute of Enze Medical Health Academy, Department of Radiation Oncology, Taizh…. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Science and Technology Plan Project of Taizhou, National Natural Science Foundation of China, Science, Technology and Innovation Commission of Shenzhen Municipality.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Radiotherapy (RT) is the mainstay treatment modality for lung cancer. We recently reported that conventionally fractionated radiotherapy (CRT) with daily fractionation of 2Gy significantly increased the activity of indoleamine 2,3-dioxygenase (IDO1), a known immune checkpoint, which predicted poorer long-term survival in patients with non-small cell lung cancer (NSCLC), while stereotactic body radiotherapy (SBRT) using fractionation size of 10Gy did not increase IDO1 activity and had better survival. Here we hypothesized that the hypofractionated SBRT kind of dose fraction stimulates host antitumor immunity via downregulating IDO1 in which CRT could not. We tested this hypothesis in vitro and in vivo using 10Gyx1 and 2Gyx8 fractionations in the laboratory. The results demonstrated that, although there was an initial downregulation after RT, the expression of IDO1 was ultimately upregulated by both fractionation regimens. The 10Gyx1 regimen had minimum upregulation, while the 2Gyx8 regimen significantly increased in IDO1 expression which was positively correlated with the elevated expressions of p-NF-κB and COX2. Pharmacological inhibition of COX2 abolished RT-induced IDO1 expression. Furthermore, the IDO1 inhibitor, D-1-methyl-tryptophan (D-1MT), exerted RT-related tumor-killing effects in the NSCLC cell lines and mouse models. These findings suggest that, in addition to being an immune suppressor, IDO1 may serve as an adaptive resistance factor in RT. Furthermore, an unappreciated mechanism may exist, where a larger fraction size might be superior to conventional sizes in cancer treatment. This study may provide a rationale for future research in using IDO1 as a biomarker to personalize RT dose fractionation and COX2 inhibitor to decrease radiation immune suppression from CRT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungLung NeoplasmsMiceAnimalsHumansNF-kappa BCyclooxygenase 2Cyclooxygenase 2 InhibitorsIndoleamine-Pyrrole 2,3,-Dioxygenase

Stichwörter der Autor:innen

COX2CRTD-1MTIDO1NSCLCSBRT

Substanzen

NF-kappa BCyclooxygenase 2Cyclooxygenase 2 InhibitorsIndoleamine-Pyrrole 2,3,-Dioxygenase

Autor:innen und Institutionen

  • Key Laboratory of Radiation Oncology of Taizhou, Radiation Oncology Institute of Enze Medical Health Academy, Department of Radiation Oncology, Taizhou Hospital Affiliated to Wenzhou Medical University, Zhejiang Provinc…
  • The Fifth Affiliated Hospital of Wenzhou Medical University, Lishui Municipal Central Hospital, Department of General Medicine, Lishui 323000, Zhejiang Province, China.

Förderung

  • Science and Technology Plan Project of Taizhou
  • National Natural Science Foundation of China
  • Science, Technology and Innovation Commission of Shenzhen Municipality
  • Taizhou Science and Technology Bureau
  • Science and Technology Planning Project of Shenzhen Municipality
  • Basic Public Welfare Research Program of Zhejiang Province

Zitieren

APA

Lan, Y., Pi, W., Zhou, Z., Meng, Y., DanMei, Xu, Y., Xia, X., WeiWang, Yang, H., & Spring Kong, F. M. (2023). Effect of radiation fractionation on IDO1 via the NF-κB/COX2 axis in non-small cell lung cancer. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2023.110956

Vancouver

Lan Y, Pi W, Zhou Z, Meng Y, DanMei, Xu Y, et al. Effect of radiation fractionation on IDO1 via the NF-κB/COX2 axis in non-small cell lung cancer. International Immunopharmacology. 2023. doi:10.1016/j.intimp.2023.110956

BibTeX
@article{Lan2023,
  author = {Lan, Yanli and Pi, Wenhu and Zhou, Zhangjie and Meng, Yinnan and DanMei and Xu, Yixiu and Xia, Xinhang and WeiWang and Yang, HaiHua and Spring Kong, Feng-Ming},
  title = {Effect of radiation fractionation on IDO1 via the NF-κB/COX2 axis in non-small cell lung cancer},
  journal = {International Immunopharmacology},
  year = {2023},
  doi = {10.1016/j.intimp.2023.110956}
}
Kostenlos starten →